Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PT Royal Prima Tbk's Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was Rp-23,763 Mil. Therefore, PT Royal Prima Tbk's EV-to-EBIT ratio for today is -13.19.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, PT Royal Prima Tbk's Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was Rp-19,242 Mil. Therefore, PT Royal Prima Tbk's EV-to-EBITDA ratio for today is -16.29.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, PT Royal Prima Tbk's Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was Rp329,891 Mil. Therefore, PT Royal Prima Tbk's EV-to-Revenue ratio for today is 0.95.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
PT Royal Prima Tbk (ISX:PRIM) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-23,763 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-19,242 Mil.
PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp329,891 Mil.
PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp14,099 Mil.
PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil.
PT Royal Prima Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp3,740 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Royal Prima Tbk Enterprise Value Related Terms
PT Royal Prima Tbk Enterprise Value Historical Data
* Premium members only.
The historical data trend for PT Royal Prima Tbk's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:PRIM vs HCA, THC, DVA: Enterprise Value Comparison
For the Medical Care Facilities subindustry, PT Royal Prima Tbk's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Royal Prima Tbk Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's Enterprise Value distribution charts can be found below:
* The bar in red indicates where PT Royal Prima Tbk's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
PT Royal Prima Tbk's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of Rp313,536 Mil mean?
PT Royal Prima Tbk (ISX:PRIM) has a Enterprise Value of Rp313,536 Mil as of Jul. 14, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on PT Royal Prima Tbk and its competitors.
Is PT Royal Prima Tbk's Enterprise Value too high?
PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil. Overall, PT Royal Prima Tbk has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's Enterprise Value compare to HCA and THC?
PT Royal Prima Tbk's Enterprise Value of Rp313,536 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on PT Royal Prima Tbk and its competitors. PT Royal Prima Tbk's current Enterprise Value is Rp313,536 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp81.59, compared to a current price of Rp98.00 — trading 20.1% above its estimated fair value. The current Enterprise Value is Rp313,536 Mil. PT Royal Prima Tbk's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current Enterprise Value is Rp313,536 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp98.00 is trading 20.1% above its estimated GF Value™ of Rp81.59.
GuruFocus considers PT Royal Prima Tbk to be Modestly Overvalued.
Key valuation signals for ISX:PRIM:
Enterprise Value: Rp313,536 Mil
GF Value™: Rp81.59 vs. price of Rp98.00 (20.1% above fair value)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
74GF Score
Get the complete analysis for ISX:PRIM
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
